Xtant Medical Holdings Inc (XTNT) is a Healthcare · Medical Devices company listed on NYSE MKT. Price $0.33 (-0.28%), Market cap $0.07B, P/E ratio 46.56, 52-week low–high $0.45 ~ $0.92.
Xtant Medical Holdings, Inc. provides regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. It offers OsteoSponge, a natural scaffold for cellular in-growth; OsteoSelect DBM Putty, a moldable demineralized bone matrix; OsteoSelect PLUS DBM Putty to deliver handling properties and ensure patient safety through validated and terminal sterilization; 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone; OsteoFactor Pro, a processed allograft that contains retained growth factors found within the endosteum layer of allograft bone; OsteoVive Plus, an aseptically
Financial statements, price targets, institutional (13F) holdings and related news for Xtant Medical Holdings Inc are updated in real time on BlackAll Trade.
Xtant Medical Holdings Inc trades at $0.33 (-0.28%). Real-time quotes and charts are available on BlackAll Trade.
Xtant Medical Holdings Inc has a market cap of about $0.07B. Its P/E ratio is 46.56.
Xtant Medical Holdings, Inc. provides regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. It offers OsteoSponge, a nat